The appearance of new deadly diseases like cancer and the burgeoning problem of drug resistance among common bacteria l pathogens are a serious threat to a vailable trea tments. Since the channels of compounds under development are limited, this necessitates the discovery of new drugs. It is where actinomycetes can complement in the accomplishment of development of thera peu tically new bioactive compounds, predomina ntly u sed in antibiotic production. Actinomycetes are diverse in their location and have proven ability to produce new bioactive compounds. By employing modern microbiological and molecular technologies, the target-directed search for detection and isolation of bioactive actinomycetes is gaining more strength. Therefore, the innova tive isolation of actinomycetes from extreme ecosystems, their identification and cultivation using novel techniques are imperative to pursue for drug discovery.
Introduction
Natural products are the chemical substances produced by living organisms of any source such as plants, animals or microorganisms. Some of the natural products have historically been proved to be the backbone of modern drug discovery efforts either from microorganisms (e.g., doxorubicin from Streptomyces peucetius), plants (e.g., paclitaxel from Taxus brevifolia) or animals (e.g., vitamins A and D from cod-liver oil). The discovery of natural compounds as active principles was first described in the beginning of 19 th century. Morphine produced and commercialized by E. Merck for the firsttime in1826, was one among the first isolated compounds. Today in pharmacology drugs of diverse range which represent the keystone of modern healthcare are either natural products or their derivatives (Chin et al., 2006) . In 2001, eight of the 30 top-selling drugs (i.e., simvastatin, pravastatin, amoxicillin, clavulanic acid, azithromycin, ceftriaxone, paclitaxel and cyclosporine), amounting US $16 billion in sales, were natural products or their derivatives (Sarker and Nahar, 2006) . The most commonly known natural resources continue to provide molecules of greater structural diversity and offer major opportunities for the discovery of drug leads. Microbial diversity represents an important route to the discovery of new chemical entities and constitutes a prominent reservoir of novel chemistry and innovative biotechnology. The microbes are considered as miniatures of chemical factories because of their great potential to provide broad spectrum of structurally diverse secondary metabolites that in turn possess diverse biological activities and are therefore, prospective candidates for drug discovery. Of the total bioactive compounds isolated from microorganism, 45% are produced by actinomycetes, 38% by fungi, and 17% by other bacteria, thus among microbes, actinomycetes are economically and biotechnologically important (Berdy, 2005) . Actinomycetes are group of gram-positive filamentous bacteria found in both terrestrial and aquatic ecosystems. After the isolation of actinomycin and streptomycin from actinomycetes, they have taken their prominent and permanent place in antibiotic research (Schatz et al., 1944) . The initial work on actinomycetes was carried by Selman Waksman (1950) and this persuaded many others to carry research on them. From 1940s and 1950s, considered as the golden era of antibiotic research, most of the antibiotics were isolated and discovered mainly from streptomyces species. Of the total antibiotics discovered, about 80% of them were isolated from actinomycetes, mostly from genera, Streptomyces and Micromonospora (Pandey et al., 2004) . A representative list of antibiotics with clinical significance produced by actinomycetes are Kanamycin, Gentamycin, Neomycin, Streptocin, Streptomycin, Chloramphenicol, Novobiocin, Spectinomycin, Thiostrepton, Lincomycin, Clindamycin, Thiostrepton, Ramoplanin, Vancomycin, Teicoplanin, Streptothricin, Daptomycin, Carbomycin, Erythromycin, Oleand omycin, Spiramycin, Abyssomicins, Rifamycin, Pyridomycin, Streptogramin A, Micromonosporin, Chlortetracycline, Oxy tetracycline, Thiolactomycin, Bonactin, etc. (Mahajan and Balachandran, 2014) . Actinomycetes are also recognised as potential source of antitumor compounds, majority of them have clinical importance such as peptides (bleomycin and actinomycin D), anthracyclines (aclarubicin, daunomycin and doxorubicin), enediynes (neocarzinostatin), aureolic acids (mithramycin), antimetabolites (pentostatin), carzinophilin, mitomycins (Olano et al., 2009) . As actinomycetes have long been known as the excellent source of therapeutic compounds, the search for novel therapeutic agents is in progress and one of the major goals of microbiologists is to isolate from them, undetected new bioactive molecules. Selection of novel antibiotics from actinomycetes has intensely been carried by researchers through several years. Only a fraction of compounds isolated from Streptomyces are known. The isolation of remaining battery of compounds requires screening of unexplored environments and utilising novel techniques of study (Ramazani et al., 2013) . It is thus, suggested to concentrate on those actinomycetes, inhabiting extreme ecosystems. Since these actinomycetes are not part of the previously isolated ones, there is high probability that these actinomycetes may be source of novel bioactives. Thus, taxonomists, biotechnologists, ecologists and several other scientists focus on those unexplored regions inhabited by novel actinomycetes and utilise novel selective isolation strategies (Baltz, 2008) . Hence, this review covers the present scenario of diversity of actinomycetes, their bioactive compounds and even the possibilities to get novel actinomycetes that may have potential to produce novel compounds.
Actinomycetes and their biotechnological importance
The word "actinomycetes" is a combination of two Greek words "atkis" (a ray) and "mykes". These microorganisms resemble both fungi (to form mycelia of branching filaments) and bacteria (the structure of muramic acid containing bacterial cell wall). Actinomycetes are a heterogeneous group of high GC gram-positive bacteria. They are free living, filamentous, aerobic, saprophytic bacteria, cosmopolitan in their distribution, mostly found in terrestrial, aquatic environments and are also found colonizing plants. They are diverse in their chemical composition, morphology and show distinct evolutionary lineage. They are classified in the Kingdom: Bacteria, Phylum: Firmicutes, Class: Actinobacteria, Subclass: Actinobacteridae, eight diverse families such as Streptomyceteceae, Micromonosporaceae, Actinomycetaceae, Frankiaceae, Mycobacteriaceae, Actinoplanaceae, Dermatophilaceae and Nocardiaceae, which comprises sixty three genera. They show filamentous structure which can be branched to form a stable mycelium. The mycelium is not always intact or stable and may break into rod or coccus shaped fragments. When grown, the actinomycetes branch profusely both on the surface of agar and underneath it, forming a network of mycelia. The mycelia growing on the surface are called aerial mycelia, and those beneath the agar surface are called substrate mycelia (Balagurunathan and Radhakrishnan, 2010) . Aerial mycelia bear spores or conidia which are reproductive parts employed in asexual reproduction. There is a great variation in cell wall composition among different groups of actinomycetes and this is considered as a characteristic feature for the identification and classification of novel genera of class actinobacteria.
Actinomycetes are considered as valuable repositories of bioactive metabolites. Isolation, characterization and screening of promising strains of actinomyceteshas seen to produce potential secondary metabolites and has attracted attention of major researchers worldwide. Among various genera of actinomycetes; Saccharopolyspora, Micromonospora, Amycolatopsis, Streptomyces and Actinoplanes are commercially important producers of biomolecules (Solanki et al., 2008) . They are used as antibiotics against different microorganism, can kill cancerous cells, suppress immune system to protect against autoimmune diseases and are targeted as antiparasitic and antifungal agents. In plant biotechnology, these metabolites are used as pesticides and herbicides. About 70% of all known drugs have been isolated from actinomycetes. Of this percentage, 75% is used in medicine and 60% in agriculture (Atta, 2009) . Actinomycetes are considered important not only because of potent therapeutic activities associated with their extracts but also for the fact that they often possess desired pharmacokinetic characteristics required for clinical advancement (Farnet and Zazopoulos, 2005) . The actinomycetes are important not only in the field of pharmaceutical industries but also in the agriculture. The potential of actinomycetes to inhibit the growth of phytopathogens is of worth consideration, e.g., Agrobacterium tumefaciens that causes crown gall disease in plants, Erwinia amylovora that causes fire blight to apple, etc. (Jeffrey et al., 2007) . Apart from this, actinomycetes have major contribution in biological buffering of soils, biodegradation of hydrocarbons of high molecular weight and biocontrol of terrestrial environments by processes like nitrogen fixation, etc. They are also capable to synthesize diverse range of biologically active secondary metabolites such as vitamins, herbicides, nutritional materials, cosmetics, etc. (Ogunmwonyi et al., 2010) .
Role of actinomycetes as potential antibiotic producers
The antibiotics are the secondary metabolites produced by actinomycetes. Antibiotics are truly referred as the 'wonder drugs' for their virtual success against pathogenic microorganisms. These noteworthy compounds are heterogeneous collection of biologically active molecules and possess diverse structures and modes of action. Among its targets are microbial processes such as DNA, RNA and protein synthesis, electron transport chain, membrane function, germination, sporulation and many others (Kohanski et al., 2010) . Thus, antibiotics serve as efficient targets for microbial infections. Before the antibiotics were discovered, people with simple wounds and infectious diseases could not be treated. The global demand for antibiotics is progressively increasing. The leading forms of infection, that are difficult to treat due to increased resistance of pathogenic organisms has further complicated the situation, as in the case of Klebsiella pneumonia resistant strains against carbapenem and other microorganisms (Procopioa et al., 2012) . These resistant strains show limited or no response to treatment, thereby cause prolonged illness and pose serious threat to life. Resistance thus causes treatment failures, prolong phase of infectivity which increases the number of people infected within the community. The situation becomes more aggrieved when population contracts a multidrug-resistant (MDR) strain (Costelloe et al., 2010) .
To improve healthcare, actinomycetes especially streptomyces species hold prominent position to produce a wide variety of compounds particularly once that are used as drugs of significant medicinal importance (Table 1) (Magarvey et al., 2004) . Multidrug resistance by pathogens poses a challenge to search for new antibiotics which are effective against these pathogenic bacteria. Successful efforts are made to isolate natural products having novel structures that possess useful biological activities (Dancer, 2004) . It is accepted that substantial progress is being made by biochemists and biotechnologists to synthesize chemical products used against pathogenic bacteria, but nature still possesses a reservoir of resources and an enormous potential to produce products of novelty to be used against these antimicrobial resistant strains (Bull and Stach, 2007) . Of all the antibiotics produced, 80% alone come from actinomycetes. Streptomyces and Micromonospora are the two genera, producing most of the actinomycete antibiotics. The actinomycete antibiotics are classified into several major structural groups such as amino glycosides, ansamycins, anthracyclines, -lactam, macrolides and tetracycline (Nanjawade et al., 2010) . Streptomyces, the soil inhabitants compete with other soil microorganism and produce many of the compounds to kill its competitors (Laskaris et al., 2010) . More than one antibiotics are produced by some actinomycetes (e.g., Streptomyces griseus) and different actinomycete species may produce the common antibiotic (e.g., streptothricin, actinomycin). Identical antibiotics may thus be produced from different actinomycetes as shown by its antibiotic spectrum and chemical composition. 
Role of actinomycetes as potential producers of antitumour agents
According to the World Health Organization, cancer is second killer after the cardiovascular disease and one of the top ten diseases affecting people worldwide. The reports are more specific when calculated in third world countries. In spite of recent investigations in cancer biology regarding its induction and progression and the success obtained thereafter, cancer still remains the most threatened disease affecting people worldwide. Although treatments for different types of cancers vary from surgery to several chemotherapies like immunotherapy, radiotherapy, hormonal therapies and anti-angiogenesis; more advanced treatments are still awaiting. In this regard, actinomycetes especially streptomyces provide a promising hope to be used as producers of clinically useful antitumour agent (Table 2) . Emphasis is laid on the production of novel antitumour drugs that can be used against untreatable tumours and against those tumors resistant to multiple chemotherapeutic drugs. By employing novel drugs, undesirable side effects along with increased toxicity usually associated with conventional drugs is also thought to be eliminated. In addition, there is a demand for novel drugs with greater therapeutic efficiency (Olano et al., 2009 ). 
Ecology of actinomycetes
The fundamental concept of biogeography, "everything is everywhere, but the environment selects" has been widely propagated in ecological studies. Traditionally, the field encompasses studies of spatial distribution of plants and animals with relation to time. This concept is undergoing rapid changes with the inclusion of microorganisms in this discipline. With reference to microbial community, the concept has been interpreted as, most bacteria are cosmopolitan (everything is everywhere) and bacteria thrive in those places where they adapt themselves to the surrounding environment and the later selects them (the environments selects). Several findings have supported the biogeographical patterns in microbial distribution (Wawrik et al., 2007; Hanson et al., 2012; Nemergut et al., 2011) . Take the case of geographical distribution of Roseobacter cluster that grows in polar and temperate regions and does not grow in tropical and subtropical regions (Selje et al., 2004) . Another marine bacterium, Prochlorococcus marinus, that grows in tropical and subtropical ocean water surfaces where it can be isolated but cannot be obtained from temperate and polar ocean surfaces. Some populations of actinomycetes adapt to both high and low light conditions and are found in different photic zones of oceans, e.g., Prochlorococcus species. Actinobacteria form one of the largest phylum of bacteria (Gao and Gupta, 2012) and an appropriate candidate for their biogeographical studies. Most of the actinomycetes are cosmopolitan in habitat and free living in different natural habitats such as soil, freshwater ecosystems, marine habitats and plant tissues. Of the total number of actinomycete genera, streptomyces species are found abundantly.
Actinomycetes in terrestrial environments
Actinomycetes constitute a large part of soil inhabitant microbes. The strong odour in the air when rain falls after a dry spell of weather is due to production of geosmin by the soil actinomycetes (Gust et al., 2003) . Actinomycetes are abundant soil inhabitants, found in different types of soils such as desert soil, alkaline soil, salt soils and frost soils under the snow caps. The initial work on soil actinomycetes began in the last decades of the 19 th century. But intensive studies on actinomycetes started only in 1943 with the discovery of streptomycin from Streptomyces griseus, the first successful drug against tuberculosis. Many actinomycetes have since then been isolated mostly with the objective of discovering new antibiotics. Majority of the actinomycetes have been isolated from soils (Abdulla, 2009) . Rhizospheric soil forms a good host for many actinomycetes. However, the distribution of actinomycetes, especially the population density and diversity, seems to differ between rhizophere and other plant-free non-rhizospheric soil litter (Nimnoi et al., 2011) . Rhizopheric soil seems to contain more diverse actinomycetes compared to non-rhizospheric soil. This high diversity may be due to symbiotic interactions with the plant and the edaphic conditions. The plant type may also influence the diversity of actinomycetes in the soil. Many researchers studied soil actinomycete community, using molecular biology tools and reported most of them to be unculturable (Priyadharsini and Dhanasekaran, 2015) .
Actinomycetes in aquatic environments
Aquatic environments form the largest ecosystem on the earth. Marine habitats cover nearly two-thirds of the earth's surface. These large but unexplored habitats have been reported to contain diverse actinomycete communities (Valli et al., 2012) . It is reported that Streptomyces forms a dominant genus in water bodies while Micromonospora flourishes under sediments (Sharma and David, 2012) . The genera, Marinispora, Salinibacterium, Salinispora, Serinicoccus and Solwaraspora are unique to marine habitats.
Freshwater ecosystems have been reported as promising source of bioactive actinomycetes (Hodges et al., 2012) .
Actinomycetes in special habitats
Natural product resources have not been explored fully. They have been explored from the conventional environments, but their exploration from the extreme habitats is limited. Recently, they have been reported from wide variety of geographical ranges, different ecological conditions and extreme environments. It is presumed that millions of microbes await their discovery and their capacity to produce natural products of desirable medicinal value is unreported. Organisms growing in unusual habitats have unique physiological and biochemical characteristics, producing niche specific secondary metabolites which enable them to thrive in such extreme conditions of higher salinity, pH, pressure and temperature. The unique bioactive compounds which may be produced through this process may have commercial applications. Permeation of biotechnology into marine environment has ushered in unanticipated strategies for locating novel organisms and trapping their potential of producing bioactive compounds. Reservoirs of unidentified, untapped and unexplored natural products are buried under the ocean sediments, covering 70% of the earth's surface. The factories of these natural products are microorganisms, residing in deep ocean sediments. Among these, microorganisms actinomycetes are our focus of attention. Actinomycetes from these ocean sediments are said to be obligate marine inhabitants (Maldonado et al., 2005) . It is expected that the genetic makeup and the metabolic composition of these actinomycetes is unknown and, hence, the possibility of getting novel metabolites of medicinal value are higher (Bull and Stach, 2007) . Previous studies on the chemical structure and composition of marine Actinomycetes has revealed that they possess novel secondary metabolites, active against human tumours and other diseases (Blunt et al., 2007) . The discovery of widespread populations of Salinispora (formerly Salinospora)-an obligate marine actinomycete genus from the ocean sediments by Fenical's research group was a breakthrough (Mincer et al., 2005) . Later, Salinispora strains were isolated from sponges of some ocean reefs like the sponge, Pseudo ceratinaclavata inhabiting Great Barrier Reef. Novel actinomycetes have also been reported from other Great Barrier Reef sponges like Rhopaloeides odorabile, Pseudo ceratinaclavata and Candida spongiaflabellate and sponges inhabiting the Mediterranean sea like Aplysina aerophoba and Theonella swinhoei (Kim et al., 2002) . Actinomycetes isolated from these sponges are uncommon; belong to Gordoniaceae, Micrococceae and Dermatophilaceae families. These sponge associated actinomycetes produce novel bioactive metabolites (Hill, 2004) . Actinomycetes inhabit either in isolation under deep sea floor and marine snow or in association with marine invertebrates and form an exclusive group of these unique ecosystems. The actinomycetes adapted themselves to these high pressure and low temperature unique ecosystems and produced an enormous reservoir of secondary metabolites to be exploited for practical biomedical applications. Even, if the study on exploitation of actinomycetes from these extreme marine ecosystems is moving with snail's pace, the truth that several novel metabolites have been secluded in the past few years, makes it an advanced field of research to be dealt with due consideration .
The microorganisms also thrive in caves and mines and such environments are the hypogean environments. Like marine and acidophilic environments, hypogean environments are unexploited for their microbial diversity. Light cannot reach in caves and because hypogean environments have high concentrations of inorganic minerals; such ecosystems provide inorganic energy sources rather than on organic sources (Peck, 1986) . The microbes inhabiting these ecosystems, usually transport organic matter, if any from outside by seepage water. Such inputs of organic matter from outside the hypogean environments are called allochthonous (extrinsic) input of organic matter (Laiz et al., 1999) . These dark environments with no light, limited organic matter and high mineral content form limiting ecosystems and provide ecological niches for highly specialized organisms. Hypogean ecosystems are further fragmented into various microhabitats which differ in their community structure. It was earlier reported that actinomycetes can be isolated from limiting ecosystems including these hypogean environments and these microorganisms can be used for screening of valuable bioactive metabolites. In Northern Spain, Italy, Korea and China, the studies of the biodiversity of caves and mines have revealed that actinomycetes form an abundant taxonomic group (Wang et al., 2009) . Hence, actinomycete genera like Fodinibacter, Beutenbergia, and Knoellia as have been isolated from these hypogean environments. Among less isolated ones, isolated from Italian, Spanish and Korean caves, mines and catacombs are Jiangella, Kribbella, Isoptericola, Nocardia, Myceligenerans, Actinocorallia, Amycolatopsis, Agromyces, Saccharothrix, and Pseudonocardia (Jurado et al., 2008) .
Identification and characterization of actinomycetes
The techniques like DNA-DNA hybridization, conserved region based PCR analysis and cloning of rRNA genes provides a more accurate and rapid method of comparing relatedness (Gentry, 2006) . The 16S rRNA gene method has aided in finding phylogenetic relationships at species level, degree of similarity between the genomes of different species, and is therefore useful for defining proposed new species as well as the perfect assignment of a particular existing strain with ambiguous properties to the correct taxonomic group (Cho and Tiedje, 2001) . In actinomycete classification, phenotypic methods like morphological, physiological and biochemical characterization and phylogenetic methods like molecular characterization are employed as a polyphasic taxonomic approach. Growth and morphology of streptomyces spp. are observed when cultures turned mature with heavy spore mass in order to determine diffusible pigments colour, substrate mycelium and aerial spore mass colour. Colour grouping is done to differentiate between large number of different isolates. However, this study only involves streptomyces spp. As such, morphological observation is considered stable and clearly defined feature for actinomycetes classification.
The polymorphism in DNA was studied using several genetic markers in plant breeding methods like RFLP, AFLP, microsatellites genomic sequencing, rRNA sequencing, isoenzymes, and in some cases, random amplified polymorphic DNA (RAPD) technique has been used for identification of individuals in different populations and for distinguishing isolates of various phytopathogens. The later method being simple, inexpensive and does not require any sequence information, has been widely used for estimating genetic diversity in natural populations. By employing the 16S rRNA gene sequence comparisons, it is presumed that a major fraction of microorganisms inhabiting different environments are still uncultured. Before the advent of molecular techniques, these uncultured organisms remained uncharacterized because a microorganism can only be cultivated after its physiological niche has been characterized and duplicated experimentally. Metagenomics-the culture independent genomic analysis of microbial communities provide the means to identify novel and industrially useful genes in the environment as well as understanding microbial diversity (Rodriguez-Valera, 2004 ).
Search for novel producer strains
Two techniques employed in metagenomic analysis of different microbial DNA are fluorescence in situ hybridization (FISH) and16S rRNA. Studies based on these techniques revealed that conventional techniques permit the growth of less than 1% microbes, the remaining 99% still unculturable. This phenomenon where a vast majority of microbes remained uncultured on culture plates is sometimes referred to as the great plate count anomaly (Amann et al., 1995) . It is thus, proved that vast pools of microbes have not been cultured yet and research in these so called uncultured microbes is still in infancy. By employing conventional techniques, we have excluded a swathe of microbial world who's chemical and biological potentialities remain untapped. Conversely, the potential of these uncultured microbes to produce novel products of antibiotic or other medicinal value is set aside. Hence, two challenges are ahead-the first is to understand the biosynthetic pathways of unculturable microbes by interpreting their nuclear material, the second to interpret those biosynthetic pathways that are not expressed under the standard culture conditions of culturable microbes. It is presumed that by varying different growth conditions like the pH, temperature, culture medium and/or growth vessel, via the one strain-many compounds (OSMAC) approach, novel metabolites of these undiscovered biosynthetic pathways may be expressed (Bode et al., 2002) . These challenges inform us only about a part of the story and it is difficult to predict the improvements. It is now obvious that most microorganisms need environmental signals for their growth and metabolism (Netzker et al., 2015) . To mimic, the environments of complex microbial world, innovative approaches are employed by researcher's, e.g., co-culture cultivation of microbes, but this technique is criticized since it does not account for adequate molecular complexity of the natural ecosystems. An alternative approach to override this criticism is to more fully simulate the natural environment (Ling et al., 2015) . In this capacity, the iChip (isolation chip) technology is more rewarding; here an in situ procedure is followed. A soil sample, expected to contain numerous microbial strains is diluted, followed by placing it between a semipermeable membrane and burying back in the soil. This procedure lead to the identification of a new class of antibiotics from a new species of gram-negative Proteobacteria, Eleftheria terrae that target lipid II, e.g., teixobactin. Another discovery is the isolation of closthioamide, the first secondary metabolite from Clostridium cellulolyticuma strictly anaerobic bacterium (Lincke et al., 2010) . This technology also raises the tempting opportunity of isolation and cultivation of microorganisms from remote areas, e.g., in deep ocean trenchesor other planets. In addition, genes encoding secondary metabolic biosynthetic pathways that remain quiet and probably unexpressed under standard laboratory conditions may express under these secondary growth conditions (Rutledge and Challis, 2015) . Genomic methods, e.g., heterologous gene expression and cloning can target these orphan pathways and thus increase the possibility of producing non-natural analogs. Another method to access these orphan biosynthetic pathways is to omit a separate cultivation step and directly clone DNA from microbial communities via metagenomic strategies (Owen, 2013) . These metagenomic approaches are normally either function or sequence based; the former screens and identifies cloned environmental DNA and evaluates the activity of their expression products, more specifically proteins as novel bioactive metabolites. The later concentrates on genes linked with production of specific natural products (Milshteyn et al., 2014) .
Conclusion
The demand for improved tumour treatment and appearance of multidrug-resistant strains encourages a continuous exploration of natural bioactive metabolites. As the scope of naturally found bioactive compounds increases day-by-day, the search for novel active biomolecules increases. Diverse microbial world as a source of natural product resources, are mostly unexplored by the scientific world with respect of its ecological and environmental points of view. It is presumed that unique organisms may inhabit unique ecosystems with unique metabolic pathways. Screening of these unknown species from unexplored regions may yield enormous potential. The research on activities of bioactive molecules produced by microorganism inhabiting extreme environments has geared up. Among all microbes, actinomycetes have proved to have enormous potential to produce molecules of unique bioactivity. The effective exploration of uncommon and unreported groups of various microbes predominantly novel actinomycetes can greatly be increased with the application of new molecular techniques, which in turn may greatly increase the chemical diversity of bioactive compounds to be used as potent therapeutic agents. Attempts are on to discover novel actinomycetes and along with the existing ones, exploit their bioactive potential of producing molecules with practical applications.
